Institute of Neurology, University College London, Queen Square, London, UK.
Wellcome Centre for Human Neuroimaging, University College London, 12 Queen Square, London, UK.
Acta Neurochir (Wien). 2020 Dec;162(12):3055-3065. doi: 10.1007/s00701-020-04561-w. Epub 2020 Oct 2.
Awake craniotomy is the standard of care in surgery of tumours located in eloquent parts of the brain. However, high variability is recorded in multiple parameters, including anaesthetic techniques, mapping paradigms and technology adjuncts. The current study is focused primarily on patients' level of consciousness, surgical technique, and experience based on a cohort of 50 consecutive cases undergoing awake throughout craniotomy (ATC).
Data was collected prospectively for 46 patients undergoing 50 operations over 14-month period, by the senior author, including demographics, extent of resection (EOR), adverse intraoperative events, surgical morbidity, surgery duration, levels of O saturation and brain oedema. A prospective, patient experience questionnaire was delivered to 38 patients.
The ATC technique was well tolerated in all patients. Once TCI stopped, all patients were immediately assessable for mapping. Despite > 75% of cases being considered inoperable/high risk, gross total resection (GTR) was achieved in 68% patients and subtotal resection in 20%. The average duration of surgery was 220 min with no episodes of hypoxia. Early and late severe deficits recorded in 12% and 2%, respectively. No stimulation-induced seizures or failed ATCs were recorded. Patient-recorded data showed absent/minimal pain during (1) clamp placement in 95.6% of patients; (2) drilling in 94.7% of patients; (3) surgery in 78.9% of patients. Post-operatively, 92.3% of patients reported willingness to repeat the ATC, if necessary.
The current ATC paradigm allows immediate brain mapping, maximising patient comfort during self-positioning. Despite the cohort of challenging tumour location, satisfactory EOR was achieved with acceptable morbidity and no adverse intraoperative events.
在位于大脑功能区的肿瘤手术中,清醒开颅术是标准的治疗方法。然而,在包括麻醉技术、映射范式和技术辅助在内的多个参数中,记录到了高度的可变性。目前的研究主要集中在 50 例连续接受清醒开颅术(ATC)的患者的意识水平、手术技术和经验上。
通过资深作者,前瞻性地收集了 46 名患者的 50 例手术的数据,包括人口统计学数据、切除范围(EOR)、术中不良事件、手术发病率、手术持续时间、O 饱和度和脑水肿水平。向 38 名患者发放了一份前瞻性的患者体验问卷调查。
ATC 技术在所有患者中均能很好地耐受。一旦 TCI 停止,所有患者都可以立即进行映射评估。尽管超过 75%的病例被认为是不可手术/高风险的,但仍有 68%的患者实现了全切除(GTR),20%的患者实现了次全切除。手术平均持续 220 分钟,没有缺氧发作。分别有 12%和 2%的患者出现早期和晚期严重缺陷。没有记录到刺激诱导的癫痫发作或 ATC 失败。患者记录的数据显示,在 95.6%的患者中,(1)夹钳放置期间无/轻微疼痛;(2)在 94.7%的患者中,钻孔期间无/轻微疼痛;(3)在 78.9%的患者中,手术期间无/轻微疼痛。术后,92.3%的患者表示,如果需要,愿意再次接受 ATC。
目前的 ATC 范式允许立即进行脑映射,最大限度地提高了患者在自我定位时的舒适度。尽管肿瘤位置具有挑战性,但仍实现了令人满意的 EOR,发病率可接受,且无术中不良事件。